Nine states have been pursuing the idea of prescription drug affordability boards. Maryland's board just set limits on the ...

Fresh tax cuts, an instant $1,000 tax reduction and cheaper medicines: here's what the federal government's latest budget means for Australians.

I had read countless legal documents about the world's bestselling drug. But it took a trip to Latin America to see how scarcity shapes life and death decisions.

Merck falls 7% despite an earnings beat as a pipeline setback and Gardasil weakness act as dampeners. However, Keytruda and new launches support growth.

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Eli Lilly’s diabetes drug Mounjaro has become the world’s top-selling medication, surpassing Merck’s cancer therapy Keytruda. Lilly’s performance compounded when Mounjaro and weight-loss drug Zepbound ...

Merck reported higher first-quarter sales and raised its full-year earnings guidance as demand for its flagship Keytruda cancer drug continues to grow. Sales rose 5% to $16.29 billion, boosted by 12% ...

Top insights from the latest market news from Thursday, April 30, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.

Merck narrows 2026 outlook, but analysts see revision as less compelling Investors focus on pipeline and efforts to reduce reliance on Keytruda Merck booked $3.62-per-share charge for Cidara buyout ...

Merck reported first-quarter results that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products.  The pharmaceutical giant also narrowed its 2026 sales ...

Merck reported higher first-quarter sales and raised its full-year earnings guidance as demand for its flagship Keytruda cancer drug continues to grow. Sales rose 5% to $16.29 billion, boosted by 12% ...